222 related articles for article (PubMed ID: 11292779)
1. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosely related homologue, the B subunit of cholera toxin.
Millar DG; Hirst TR; Snider DP
Infect Immun; 2001 May; 69(5):3476-82. PubMed ID: 11292779
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile toxin A carboxyl-terminus peptide lacking ADP-ribosyltransferase activity acts as a mucosal adjuvant.
Castagliuolo I; Sardina M; Brun P; DeRos C; Mastrotto C; Lovato L; Palù G
Infect Immun; 2004 May; 72(5):2827-36. PubMed ID: 15102793
[TBL] [Abstract][Full Text] [Related]
4. Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic.
Williams NA
Int J Med Microbiol; 2000 Oct; 290(4-5):447-53. PubMed ID: 11111925
[TBL] [Abstract][Full Text] [Related]
5. Cholera toxin and Escherichia coli enterotoxin B-subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments.
Millar DG; Hirst TR
Cell Microbiol; 2001 May; 3(5):311-29. PubMed ID: 11298654
[TBL] [Abstract][Full Text] [Related]
6. Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions.
Fraser SA; de Haan L; Hearn AR; Bone HK; Salmond RJ; Rivett AJ; Williams NA; Hirst TR
Infect Immun; 2003 Mar; 71(3):1527-37. PubMed ID: 12595472
[TBL] [Abstract][Full Text] [Related]
7. Native and mutant forms of cholera toxin and heat-labile enterotoxin effectively enhance protective efficacy of live attenuated and heat-killed Shigella vaccines.
Hartman AB; Van De Verg LL; Venkatesan MM
Infect Immun; 1999 Nov; 67(11):5841-7. PubMed ID: 10531238
[TBL] [Abstract][Full Text] [Related]
8. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus 2/6 virus-like particles administered intranasally in mice, with or without the mucosal adjuvants cholera toxin and Escherichia coli heat-labile toxin, induce a Th1/Th2-like immune response.
Fromantin C; Jamot B; Cohen J; Piroth L; Pothier P; Kohli E
J Virol; 2001 Nov; 75(22):11010-6. PubMed ID: 11602741
[TBL] [Abstract][Full Text] [Related]
10. Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens.
Marinaro M; Di Tommaso A; Uzzau S; Fasano A; De Magistris MT
Infect Immun; 1999 Mar; 67(3):1287-91. PubMed ID: 10024572
[TBL] [Abstract][Full Text] [Related]
11. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.
Richards CM; Aman AT; Hirst TR; Hill TJ; Williams NA
J Virol; 2001 Feb; 75(4):1664-71. PubMed ID: 11160664
[TBL] [Abstract][Full Text] [Related]
12. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants.
Simmons CP; Mastroeni P; Fowler R; Ghaem-maghami M; Lycke N; Pizza M; Rappuoli R; Dougan G
J Immunol; 1999 Dec; 163(12):6502-10. PubMed ID: 10586042
[TBL] [Abstract][Full Text] [Related]
13. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT).
Cheng E; Cárdenas-Freytag L; Clements JD
Vaccine; 1999 Aug; 18(1-2):38-49. PubMed ID: 10501233
[TBL] [Abstract][Full Text] [Related]
14. The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin.
de Haan L; Verweij W; Agsteribbe E; Wilschut J
Immunol Cell Biol; 1998 Jun; 76(3):270-9. PubMed ID: 9682971
[TBL] [Abstract][Full Text] [Related]
15. Modulation of B lymphocyte signalling by the B subunit of Escherichia coli heat-labile enterotoxin.
Bone H; Eckholdt S; Williams NA
Int Immunol; 2002 Jun; 14(6):647-58. PubMed ID: 12039916
[TBL] [Abstract][Full Text] [Related]
16. Nasal delivery of antigen with the B subunit of Escherichia coli heat-labile enterotoxin augments antigen-specific T-cell clonal expansion and differentiation.
Apostolaki M; Williams NA
Infect Immun; 2004 Jul; 72(7):4072-80. PubMed ID: 15213152
[TBL] [Abstract][Full Text] [Related]
17. Mutant Escherichia coli heat-labile enterotoxin [LT(R192G)] enhances protective humoral and cellular immune responses to orally administered inactivated influenza vaccine.
Lu X; Clements JD; Katz JM
Vaccine; 2002 Jan; 20(7-8):1019-29. PubMed ID: 11803061
[TBL] [Abstract][Full Text] [Related]
18. The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity.
Lycke N; Tsuji T; Holmgren J
Eur J Immunol; 1992 Sep; 22(9):2277-81. PubMed ID: 1381311
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli heat-labile enterotoxin B subunit prevents autoimmune arthritis through induction of regulatory CD4+ T cells.
Luross JA; Heaton T; Hirst TR; Day MJ; Williams NA
Arthritis Rheum; 2002 Jun; 46(6):1671-82. PubMed ID: 12115200
[TBL] [Abstract][Full Text] [Related]
20. A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.
Kweon MN; Yamamoto M; Watanabe F; Tamura S; Van Ginkel FW; Miyauchi A; Takagi H; Takeda Y; Hamabata T; Fujihashi K; McGhee JR; Kiyono H
J Infect Dis; 2002 Nov; 186(9):1261-9. PubMed ID: 12402195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
